FDA Grants Approval for Vimseltinib in Treatment of Tenosynovial Giant Cell Tumor (TGCT)
The U.S. Food and Drug Administration (FDA) has officially approved vimseltinib, marketed under the brand name Romvivza™, for the treatment ...
The U.S. Food and Drug Administration (FDA) has officially approved vimseltinib, marketed under the brand name Romvivza™, for the treatment ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine